APA (7th ed.) Citation

LABG, F., MF, S., N, P. F., LV, P. N., & EAG, d. A. (2023). Development of H51Y and E157Q mutations for integrase inhibitor resistance in a patient undergoing treatment for pulmonary tuberculosis: A case report. SAGE open medical case reports, 11, 2050313X231220786. https://doi.org/10.1177/2050313X231220786

Chicago Style (17th ed.) Citation

LABG, Farias, Saboya MF, Ponte Fernandes N, Perdigão Neto LV, and de Arruda EAG. "Development of H51Y and E157Q Mutations for Integrase Inhibitor Resistance in a Patient Undergoing Treatment for Pulmonary Tuberculosis: A Case Report." SAGE Open Medical Case Reports 11 (2023): 2050313X231220786. https://doi.org/10.1177/2050313X231220786.

MLA (9th ed.) Citation

LABG, Farias, et al. "Development of H51Y and E157Q Mutations for Integrase Inhibitor Resistance in a Patient Undergoing Treatment for Pulmonary Tuberculosis: A Case Report." SAGE Open Medical Case Reports, vol. 11, 2023, p. 2050313X231220786, https://doi.org/10.1177/2050313X231220786.